| abstract |
PROBLEM TO BE SOLVED: To provide an immunogenic composition for protecting from S. pneumoniae, particularly from S. pneumoniae serogroup 9, while limiting the number of conjugates. The present invention therefore provides a novel immunogenic composition for use in a pneumococcal vaccine, and a vaccine for human subjects, particularly infants and the elderly, against pneumococcal infection using said immunogenic composition. Regarding inoculation. [Selection] Figure 1 |